Legal Representation
Attorney
Patrick Jay Hines
USPTO Deadlines
Next Deadline
68 days remaining
Non-Final Action Mailed
Due Date
October 10, 2025
Extension Available
Until January 10, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 10, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 10, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 10, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 7, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 27, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 27, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jan 24, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jan 24, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Syringes sold filled with pharmaceuticals for the treatment of osteoarthritis and other degenerative joint diseases; Syringes sold filled with pharmaceuticals for chronic wound healing, including non-healing ulcers; Syringes sold filled with immune-modulating pharmaceuticals for autoimmune diseases and transplant rejection prevention; Syringes sold filled with pharmaceuticals for cardiovascular diseases, including acute myocardial infarction and ischemic conditions; Syringes sold filled with regenerative pharmaceuticals for skin and tissue repair; Biological tissue cultures for medical purposes; Medicinal syrups for the treatment of organ transplant rejection; Medicinal syrups for the treatment of transplant-related complications; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Biological preparations for use in cell cultures for medical purposes; Organotherapy preparations; Stem cells for medical purposes
Class 010
Apparatus for the regeneration of stem cells for medical purposes
Class 042
Providing reagent sample testing and diagnostic services for others for scientific research purposes; Providing medical and scientific research information in the field of clinical trials; Medical research laboratory services; Medical research services; Scientific research in the field of genetics; Research and development of new products for others; Technical writing; Scientific and technological services, namely, scientific research in the field of stem cell therapy and regenerative medicine, including treatments for degenerative diseases; Scientific and technological services, namely, scientific research in the field of cell-based pharmaceuticals and gene-editing technologies for chronic and acute diseases; Scientific and technological services, namely, scientific research in the field of anti-rejection therapies and regulatory T-cell technologies for organ transplantation; Technological research in the field of cell-based pharmaceutical development and manufacturing technologies; Technological research in the field of immunotherapy and gene therapy; Technological research in the field of treatments for degenerative and cardiovascular diseases; Technological research in the field of medical technology development and clinical applications; Scientific and technological services, namely, scientific research in the field of contract development and manufacturing of medical products
Additional Information
Design Mark
The mark consists of the stylized wording TAIWAN BIO THERAPEUTICS to the right of a miscellaneous design comprised of three stacked chevrons in different shading and shapes with a circle design on the bottom component.
Classification
International Classes
005
010
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
No claim is made to the exclusive right to use THERAPEUTICS, apart from the mark as shown.